✦ LIBER ✦

Effect of nuclear factor-kappa B inhibitors and peroxisome proliferator-activated receptor-gamma ligands on PTHrP release from human fetal membranes

✍ Scribed by M. Lappas; M. Permezel; P.W. Ho; J.M. Moseley; M.E. Wlodek; G.E. Rice

Book ID: 113853833
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 154 KB
Volume: 25
Category: Article
ISSN: 0143-4004
DOI: 10.1016/j.placenta.2004.02.003

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The effect of activation of peroxisome p

The effect of activation of peroxisome proliferator-activated receptor gamma (PPARγ) on human monocyte function: PPARγ ligands do not inhibit tumor necrosis factor-α release in human monocytic cell line THP-1

✍ T. Naitoh; M. Kitahara; N. Tsuruzoe 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 87 KB

Inhibitory effect of meloxicam, a select

Inhibitory effect of meloxicam, a selective cyclooxygenase-2 inhibitor, and ciglitazone, a peroxisome proliferator-activated receptor gamma ligand, on the growth of human ovarian cancers

✍ Bing Xin; Yoshihito Yokoyama; Tatsuhiko Shigeto; Masayuki Futagami; Hideki Mizun 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 308 KB

## Abstract ## BACKGROUND. It was recently reported that high expression of peroxisome proliferator‐activated receptor γ (PPARγ) and low expression of cyclooxygenase‐2 (COX‐2) might be involved in the inhibition of ovarian tumor progression and confirmed that PPARγ activation could suppress COX‐2